Association between prefrontal glutamine levels and neuroticism determined using proton magnetic resonance spectroscopy

Hasler, Gregor; Buchmann, Andreas; Haynes, Melanie; Müller, Sabrina Theresia; Ghisleni, Carmen; Brechbühl, Sarela; Tuura, Ruth (2019). Association between prefrontal glutamine levels and neuroticism determined using proton magnetic resonance spectroscopy. Translational Psychiatry, 9(1), p. 170. Springer Nature 10.1038/s41398-019-0500-z

[img]
Preview
Text
2019.HaslerGregor.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (712kB) | Preview

There is growing evidence for GABA and glutamate–glutamine dysfunction in the pathogenesis of mood and anxiety disorders. It is important to study this pathology in the early phases of the illness in order to develop new approaches to secondary prevention. New magnetic resonance spectroscopy (MRS) measures allow determining glutamine, the principal metabolite of synaptic glutamate that is directly related to glutamate levels in the synaptic cleft, as well as glutamate and GABA. In contrast to previous investigations, this study used community-based recruitment methods and a combined categorical and dimensional approach to psychopathology. In the study protocol, neuroticism was defined as the primary outcome. Neuroticism shares a large proportion of its genetic variance with mood and anxiety disorders. We examined young adult participants recruited from the general population in a cross-sectional study using 3-T 1H-MRS with one voxel in the left dorsolateral prefrontal cortex (DLPFC). The total sample of N = 110 (61 females) included 18 individuals suffering from MDD and 19 individuals suffering from DSM-IV anxiety disorders. We found that glutamine and glutamine-to-glutamate ratio were correlated with neuroticism in the whole sample (r = 0.263, p = 0.005, and n = 110; respectively, r = 0.252, p = 0.008, and n = 110), even when controlling for depression and anxiety disorder diagnoses (for glutamine: beta = 0.220, p = 0.047, and n = 110). Glutamate and GABA were not significantly correlated with neuroticism (r = 0.087, p = 0.365, and n = 110; r = −0.044, p = 0.645, and n = 110). Lack of self-confidence and emotional instability were the clinical correlates of glutamate–glutamine dysfunction. In conclusion, this study suggests that prefrontal glutamine is increased in early phases of mood and anxiety disorders. Further understanding of glutamate–glutamine dysfunction in stress-related disorders may lead to new therapeutic strategies to prevent and treat these disorders.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > University Psychiatric Services > University Hospital of Psychiatry and Psychotherapy > Translational Research Center
04 Faculty of Medicine > University Psychiatric Services

UniBE Contributor:

Hasler, Gregor; Buchmann, Andreas; Haynes, Melanie; Müller, Sabrina Theresia and Brechbühl, Sarela

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2158-3188

Publisher:

Springer Nature

Language:

English

Submitter:

Marlise Matti

Date Deposited:

01 May 2020 15:19

Last Modified:

03 May 2020 02:42

Publisher DOI:

10.1038/s41398-019-0500-z

PubMed ID:

31213596

BORIS DOI:

10.7892/boris.143769

URI:

https://boris.unibe.ch/id/eprint/143769

Actions (login required)

Edit item Edit item
Provide Feedback